ClinConnect ClinConnect Logo
Search / Trial NCT06170177

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Launched by IRCCS SAN RAFFAELE · Dec 6, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Radical Cystectomy

ClinConnect Summary

This clinical trial is looking at how the quality of life and health conditions change for patients who have had a radical cystectomy, which is a surgery to remove the bladder due to bladder cancer. The study aims to understand how this surgery affects patients' everyday lives and overall well-being. It is currently recruiting participants who are at least 18 years old and have undergone this surgery.

Eligible participants should be able to read and sign a consent form, which means they understand what the study involves. Those who join the study can expect to share their experiences and health information, helping researchers learn more about life after bladder surgery. This trial is important because it can provide valuable insights that may improve care and support for future patients undergoing similar treatments.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • subjects underwent radical cystectomy
  • \> 18 years old
  • Ability to read and sign the informed consent
  • Exclusion Criteria:
  • Age \<18 years
  • Inability to read and sign the informed consent

About Irccs San Raffaele

IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.

Locations

Milan, Mi, Italy

Patients applied

0 patients applied

Trial Officials

Francesco Montorsi, MD

Principal Investigator

IRCCS Ospedale San Raffaele

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported